A blog about what is new (and old) in the world of active implantable medical devices

Category Archives: Qinming Medical

China’s Evolving Domestic AIMD Industry

Posted on by Posted in Aerospace Taixin Technology, AIMD Business, Bradycardia, Brain Stimulation, Cardiac Contractility Modulation, Cardiac Pacing, Cardioversion/Defibrillation, CH Biomedical (Tongxin Medical Equipment), Circulatory Support, Cochlear Stimulation, Core Medical Technology, CoreRhythm, General Stim, Genlight, Hearing Impairment, Heart Failure (CHF), Leadinno Medical Valley, Lepu Medical, Lifetech Scientific, Microport, Nerve Blocking, Nurotron, Nystagmus, Pain, Parkinson's Disease, PINS Medical, PNS, Qinming Medical, Rectus Muscle Stimulation, Rishena Medical, Rocor Medical Technology, Sacral Root Stimulation, Sceneray, Seeneuro, Singular Medical, Sneuro, Spinal Cord Stimulation, Super Vision, Tachycardia, Vagus Nerve Stimulation, Yongrenxin

AIMDs made in China www.implantable-device.com

The 2015 “Made in China 2025” and subsequent domestic development initiatives have significantly benefited Chinese medical device manufacturers.  The 2015 plan  prioritized the expansion of high-tech device production with the goal of supplying 70% of China’s device market by 2025.   More recently, in 2021, the Chinese government issued the 14th  five-year plan (2021–25) that aims at making at least six Chinese companies reach the top 50 revenue-making medical device companies globally.

I was recently chatting with Victor Pikov at the First AIMD Workshop, and he mentioned that in the last couple of years the number of Chinese AIMD manufacturers have grown from 5 to over 10.  I was really surprised about the progress that China has made in the AIMD field, so this blog expands on the list of Chinese AIMD companies that Victor compiled and kindly shared with me. Continue reading→

Chinese Pacemakers by Qinming Originated in Delaware

Posted on by Posted in Bradycardia, Cardiac Pacing, Cardio-Pace, History, Qinming Medical
Pacemakers by Qingming (China)

Image Credit: Qingming

Cardio-Pace Medical, Inc was incorporated in Delaware on April 20, 1981 to develop, manufacture, and market its proprietary Durapulse(TM) cardiac pacemaker and accessory products. Although Cardio-Pace achieved sales of its pacemakers, it did not achieve profitability.  As a result, they suspended manufacturing the cardiac pacemaker in 1990. During 1985, Cardio-Pace entered into an agreement with Qinling Semiconductor to establish Qinming Medical, Inc., a Sino-American joint venture in Baoji, China, for the manufacture and distribution of cardiac pacemakers and accessory products. In 1992, Cardio-Pace sold its 49% interest in the joint venture to Qinming.

In 2010, Lepu Medical of Beijing purchased a 30.46 percent stake in Qinming as part of its efforts to forge an integrated Chinese cardiovascular products company. In 2013, Lepu completed the acquisition of Shaanxi Qinming Medical Instruments Co., Ltd.

Around that time, Qinming developed the QM7211, which was the first domestically developed dual-chamber rate-responsive pacemaker in China.  Its clinical study to evaluate it for non-inferiority against a Biotronik Talos pacemaker was successfully completed in 2015.

Today, Qinming is Lepu’s subsidiary in charge of the development, manufacture, and marketing of pacemaker products.  Their line includes single- and dual-chamber devices, as well as passive and active-fixation leads.